Canada markets open in 9 minutes

Rhythm Pharmaceuticals Inc (1RV.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
39.26-0.42 (-1.06%)
As of 08:02AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
91,926
77,428
23,638
3,154
0
-
Cost of Revenue
10,688
9,302
2,133
599
0
-
Gross Profit
81,238
68,126
21,505
2,555
0
-
Operating Expenses
Research Development
225,671
134,951
108,630
104,128
90,450
-
Selling General and Administrative
127,280
117,532
92,032
68,486
46,125
-
Total Operating Expenses
352,951
252,483
200,662
172,614
136,575
-
Operating Income or Loss
-271,713
-184,357
-179,157
-170,059
-136,575
-
Interest Expense
15,586
13,892
5,201
0
0
-
Total Other Income/Expenses Net
741
190
-790
100,000
-
-
Income Before Tax
-273,007
-184,114
-181,119
-69,612
-133,996
-
Income Tax Expense
864
564
0
0
-
-
Income from Continuing Operations
-273,871
-184,678
-181,119
-69,612
-133,996
-
Net Income
-273,871
-184,678
-181,119
-69,612
-133,996
-
Net Income available to common shareholders
-273,871
-184,678
-181,119
-69,612
-133,996
-
Basic EPS
-3.24
-
-3.47
-1.40
-3.04
-3.86
Diluted EPS
-3.24
-
-3.47
-1.40
-3.04
-3.86
Basic Average Shares
56,952
-
52,121
49,600
44,127
36,422
Diluted Average Shares
56,952
-
52,121
49,600
44,127
36,422